Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEA-070 for pain and inflammation induced by photodynamic therapy of actinic keratosis
2005-002875-34Phase 2Completed
- Sponsor
- IDEA AG
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in actinic keratosis (AK) comparing IDEA-070 with Placebo (2 arms). Primary endpoints: Effect of IDEA-070 on pain induced by photodynamic therapy, Effect of IDEA-070 on inflammation induced by photodynamic therapy and 1 more. Started Oct 2005; status: completed.
02
Drugs
diractin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2005-002875-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002875-34.